4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001861477-26-000005
EVP, Head of Research & Dev sold 16,558 shares at an average $26.13 ($432,663)
- EVP, Head of Research & Dev acquired 32,272 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 2026-07-29 | Option exercise | +32,272 | 35,552 | D: show line 1 in the form | ||
| Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 2026-07-30 | Sale | −16,508 | $26.13 | $431,354 | 19,044 | D: show line 2 in the form |
| Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 2026-07-30 | Sale | −50 | $26.17 | $1,309 | 18,994 | D: show line 3 in the form |
| Open-market sales · 16,558 sh · avg $26.13 · $432,663 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 2026-07-29 | Option exercise · Restricted Stock Units | −32,272 | 32,272 | D: show line 4 in the form |
Loading xslF345X06/form4-07312026_060701.xml…